Generic Name:
masitinib mesylate
Project Status:
Suspended
Therapeutic Area:
Amyotrophic lateral sclerosis (ALS)
Manufacturer:
AB Science SA
Brand Name:
Alsitek
Project Line:
Reimbursement Review
Project Number:
SR0766-000
NOC Status at Filing:
Pre NOC
Details
Manufacturer Requested Reimbursement Criteria1:
Masitinib mesylate film-coated tablets in combination with riluzole is indicated for treatment of adult patients with amyotrophic lateral sclerosis (ALS).
Submission Type:
Initial
Fee Schedule:
Schedule A
Indications:
Alsitek (masitinib mesylate) in combination with riluzole is indicated for treatment of adult patients with amyotrophic lateral sclerosis (ALS)
- The requested reimbursement criteria are provided by the applicant and do not necessarily reflect the views of CADTH. Reimbursement criteria from CADTH will be documented in the final recommendation, if applicable.